Skip to main content

Advertisement

Table 2 Characteristics of study participants

From: Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study

Characteristica Overall White men White women Black men Black women
n 13,141 3905 4721 1760 2755
Age 53.0 (7.1) 54.5 (5.7) 53.8 (5.6) 51.0 (9.0) 50.8 (8.9)
BMI 27.8 (5.7) 27.2 (3.8) 26.1 (5.0) 28.3 (5.4) 31.4 (7.2)
Waist circumference 95.9 (13.7) 98.9 (10.0) 91.5 (13.6) 97.4 (13.8) 98.1 (16.3)
SBP 120.0 (17.5) 119.2 (15.3) 116.0 (17.2) 126.4 (18.4) 123.6 (18.3)
HDL 52.6 (16.6) 43.6 (12.2) 58.9 (16.8) 48.6 (15.1) 57.1 (16.1)
Triglycerides 118. 5 (73.8) 138.6 (84.6) 119.1 (68.3) 109.5 (77.8) 95.0 (53.1)
Glucose 96.9 (9.7) 100.8 (8.8) 96.6 (8.6) 95.2 (10.3) 93.2 (10.5)
MetS severity score 0.0 (0.8) 0.3 (0.7) − 0.1 (0.8) − 0.1 (0.7) − 0.0 (0.8)
Framingham predicted 10-year CVD risk 0.101 (0.086) 0.150 (0.091) 0.061 (0.049) 0.152 (0.106) 0.069 (0.058)
ASCVD predicted 10-year risk 0.057 (0.053) 0.081 (0.052) 0.029 (0.027) 0.095 (0.062) 0.048 (0.057)
Incident CVD at 10 years; n (%) 1740 (13.2%) 959 (24.6%) 444 (9.4%) 181 (10.3%) 156 (5.7%)
Incident T2DM at 10 years, n (%) 1573 (12.0%) 456 (11.7%) 375 (7.9%) 288 (16.4%) 454 (16.5%)
  1. a All statistics are reported as mean (SD) unless otherwise noted